Femme et Homme
- | Pays :
- Germany
- France
- United States
- | Organes : -
- | Spécialités : -
Extrait
Clinical study to determine safety, tolerability, to measure how the drug is metabolized by the body and to determine the maximum tolerated dose of BAY1000394 given in an intermittent 3 days on / 4 days off schedule to patients with advanced malignancies
Critère d'inclusion
- Neoplasms